These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15674358)

  • 1. Multiple relapses and extramedullary localization with scalp and breast involvement in a case of acute promyelocytic leukaemia.
    Ammatuna E; Borza PA; Iori AP; Petti MC; Pescarmona E; Diverio D; Lo-Coco F
    Leukemia; 2005 Mar; 19(3):479-80. PubMed ID: 15674358
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of retinoic acid sensitivity in relapsed acute promyelocytic leukemia with extramedullary involvement.
    Thomas X; Fiere D; Archimbaud E
    Leukemia; 1994 Mar; 8(3):520-1. PubMed ID: 8127158
    [No Abstract]   [Full Text] [Related]  

  • 3. Central nervous system involvement at second relapse in acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Kumar B; Sharma V; Chopra A; Mahapatra M; Kumar R; Mathur S; Sazawal S; Kumar S; Saxena R
    Leuk Res; 2010 Oct; 34(10):e264-5. PubMed ID: 20537387
    [No Abstract]   [Full Text] [Related]  

  • 4. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia.
    Castagnola C; Elena C; Merli M
    Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term seventh molecular remission in acute promyelocytic leukaemia.
    Cicconi L; Romano A; Ramadan SM; Divona M; Petti MC; Lo-Coco F
    Ann Hematol; 2011 Nov; 90(11):1369-70. PubMed ID: 21336626
    [No Abstract]   [Full Text] [Related]  

  • 6. Late relapses in acute promyelocytic leukaemia.
    Latagliata R; Carmosino I; Breccia M; Minni A; Testi A; Iorio N; Lo-Coco F; Avvisati G; Petti MC; Mandelli F; Cimino G
    Acta Haematol; 2007; 117(2):106-8. PubMed ID: 17135723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
    Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
    Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current therapy of acute promyelocytic leukemia using vitamin A derivatives].
    Löwenberg B; Budel LM
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):796-8. PubMed ID: 8487880
    [No Abstract]   [Full Text] [Related]  

  • 10. Central nervous system relapse in acute promyelocytic leukemia.
    Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
    Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation therapy for acute promyelocytic leukemia.
    Fenaux P; Degos L
    N Engl J Med; 1997 Oct; 337(15):1076-7. PubMed ID: 9321537
    [No Abstract]   [Full Text] [Related]  

  • 12. Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia.
    Krishna R; Sorour Y; Goepel JR; Kirkbride P; Smith DJ; Ezaydi Y; Dalley CD; Snowden JA
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):769-71. PubMed ID: 18995171
    [No Abstract]   [Full Text] [Related]  

  • 13. Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    de Botton S; Sanz MA; Chevret S; Dombret H; Martin G; Thomas X; Mediavilla JD; Recher C; Ades L; Quesnel B; Brault P; Fey M; Wandt H; Machover D; Guerci A; Maloisel F; Stoppa AM; Rayon C; Ribera JM; Chomienne C; Degos L; Fenaux P; ;
    Leukemia; 2006 Jan; 20(1):35-41. PubMed ID: 16307026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 'standard of care' in acute promyelocytic leukemia.
    Warrell RP
    Leukemia; 1994; 8 Suppl 2():S56-8; discussion S62. PubMed ID: 7815838
    [No Abstract]   [Full Text] [Related]  

  • 15. Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
    Dvorak CC; Sanders RP; Dahl GV; Donaldson SS; Razzouk BI
    Pediatr Blood Cancer; 2007 May; 48(5):582-5. PubMed ID: 16123994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
    Lakhwani S; Raya JM; González-Brito G; Álvarez-Argüelles H; Brito ML; Hernández-Nieto L
    Pathology; 2011 Aug; 43(5):515-7. PubMed ID: 21753723
    [No Abstract]   [Full Text] [Related]  

  • 17. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia.
    Aoki A; Yoneda N; Yoneda S; Miyazono T; Sugiyama T; Saito S
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1759-63. PubMed ID: 21790892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukemia cutis in acute promyelocytic leukemia].
    del Río Garma J; Varela Gómez MR; Torres Carrete JP; Batlle Fonrodona FJ
    Sangre (Barc); 1997 Feb; 42(1):87-8. PubMed ID: 9229813
    [No Abstract]   [Full Text] [Related]  

  • 20. De-escalation of treatment for acute promyelocytic leukaemia?
    Mathews V
    Lancet Haematol; 2015 Sep; 2(9):e348-9. PubMed ID: 26685765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.